RESUMO
ETHNOPHARMMACOLOGICAL RELEVANCE: Aleurites moluccana is used in folk medicine to treat pain, fever, asthma, hepatitis, gastric ulcer and inflammatory process in general, and the nut oil had been topically applied to treat arthritis and other joint pain, however the seeds are classified as toxic for oral use. AIM: Faced with the need for new alternative to treat the symptoms and modify rheumatoid arthritis (RA) the aim of this work was to evaluate the effects of A. moluccanus' leaves dried extract in rats and mice submitted to complete Freund adjuvant (CFA)-induced RA. MATERIAL AND METHODS: Wistar Rats and Swiss mice were submitted to CFA-induced RA in the right hindpaw. They received A. moluccanus extract (orally; p.o.), dexamethasone (subcutaneously), 2â³-O-rhamnosylswertisin (p.o.) or vehicle (p.o.), from the 14th day after the CFA injection for up to 8 days. The mechanical hypersensitivity was evaluated using the von Frey filaments and the paw-oedema was measured using a plethysmometer. The rats' injected hindpaw was used to perform the histological analysis. RESULTS: A. moluccanus was able to significantly reduce the mechanical hypersensitivity in both ipsi- and contralateral hindpaws of mice injected with CFA, in a dose dependent manner. Furthermore, the paw-oedema was progressively reduced by A. moluccanus. Similar results were obtained for the positive-control drug dexamethasone and the isolated compound 2â³-O-rhamnosylswertisin. Besides the effects mentioned above, the extract was also effective to repair the joint damage in CFA-induced RA rats, including reduction of fibrosis, cartilage degradation and bone erosion scores. CONCLUSION: These results together with the literature data reinforce the anti-hypersensitivity and anti-inflammatory activity of A. moluccanus extract. Part of the observed effects is due to the presence of the compound 2â³-O-rhamnosylswertisin. The fact that the extract acted as a disease modifier point this herbal product as a promisor and safe tool to treat RA and other associated chronic diseases.
Assuntos
Aleurites/química , Artrite Experimental/tratamento farmacológico , Flavonas/farmacologia , Extratos Vegetais/farmacologia , Ramnose/análogos & derivados , Animais , Antirreumáticos/isolamento & purificação , Antirreumáticos/farmacologia , Artrite Experimental/patologia , Artrite Reumatoide/tratamento farmacológico , Artrite Reumatoide/patologia , Edema/tratamento farmacológico , Edema/patologia , Flavonas/isolamento & purificação , Adjuvante de Freund/administração & dosagem , Masculino , Medicina Tradicional/métodos , Camundongos , Extratos Vegetais/isolamento & purificação , Folhas de Planta , Ratos , Ratos Wistar , Ramnose/isolamento & purificação , Ramnose/farmacologiaRESUMO
Alzheimer's disease (AD) is a neurodegenerative disorder associated with cognitive impairment and cholinergic neuronal death, characteristic of the effect of time on biochemical neuronal function. The use of medicinal plants as an alternative form of prevention, or even as a possible treatment of AD, is therefore interesting areas of research, since the standard drugs have many side effects. Taraxerol (TRX) is a triterpene that has been isolated from several plant species, and its various pharmacological properties have already been identified, such the acetylcholinesterase (AChE) inhibition activity in vitro. There is a lack of information in literature that confirms the effect of TRX in an animal AD-like model. Seeking to fill this gap in the literature, in the present work we assessed the effect of TRX on AChE activity in the animals' encephalon and hippocampus. We also investigated the effect of TRX (1.77⯵M/side, 0.5⯵L) isolated from leaves of Eugenia umbelliflora Berg. on aversive memory impairments induced by scopolamine (2⯵g/side, 0.5⯵L) infused into rat hippocampus, and the effect of TRX (0.89 and 1.77⯵M/side, 0.5⯵L) on aversive memory impairments induced by streptozotocin (STZ) (2.5â¯mg/mL, 2.0⯵L) infused i.c.v. into mice, using the step-down inhibitory avoidance task. We found that TRX significantly inhibited AChE activity in the animal's hippocampus. Furthermore, TRX significantly improved scopolamine and STZ-induced memory impairment. Taking together, these results confirms its AChE activity inhibition in animals and indicate that TRX has anti-amnesic activity that may hold significant therapeutic value in alleviating certain memory impairments observed in AD.
Assuntos
Doença de Alzheimer/tratamento farmacológico , Disfunção Cognitiva/induzido quimicamente , Disfunção Cognitiva/tratamento farmacológico , Memória/efeitos dos fármacos , Ácido Oleanólico/análogos & derivados , Escopolamina/efeitos adversos , Estreptozocina/efeitos adversos , Acetilcolinesterase/metabolismo , Doença de Alzheimer/fisiopatologia , Animais , Aprendizagem da Esquiva/efeitos dos fármacos , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Ácido Oleanólico/farmacologia , Ácido Oleanólico/uso terapêutico , Ratos , Ratos WistarRESUMO
Phytochemical studies of Eugenia umbelliflora Berg. (Myrtaceae) resulted in the isolation of: taraxerol, alpha-amyrin, beta-amyrin, betulin and betulinic acid from the leaves, as well as trimethoxy ellagic acid from the fruits. Given that several triterpenes were found in the extracts, and that these possess gastroprotective activity, the gastroprotective activity of E. umbelliflora leaf extract was evaluated using ethanol, indomethacin, and stress-induced ulcer models in mice. The crude methanol extract was administrated (v.o) in doses of 50, 125 and 250 mg/kg. The results showed that E. umbelliflora leaves display gastro-protective activity, as demonstrated by significant inhibition of ulcer formation in the different models. The results suggest that the gastroprotective activity may be attributed, at least in part, to the triterpenes.